While body weight increased over time in both the Donor+Cas9-treated and normal diet-fed mice, the Saline group exhibited a more rapid weight gain, resulting in a gradual decline in the relative body weight of the Donor+Cas9 and normal diet-fed groups (Fig
MSM administration significantly ameliorated all these exercise-related changes, and this effect was potentiated by Vit C reaching values in some of the parameters similar to those found before competition
The new Ozempic tablets aim to close that knowledge gap
Because the conversation should not simply be about how much weight was lost
Linkova NS, Drobintseva AO, Orlova OA, Kovtun NV, Polyakova VO, Klinova SV, Mikhailova ON, Kvetnoy IM, Khavinson VKh
Eli Lilly published the results of its ATTAIN-1b trial for obesity in September 2025 7 , which compared orforglipron to placebo in more than 3,100 adults without diabetes, with a BMI of 30+ or 27-30 with an obesity-related complication including hypertension, dyslipidaemia, cardiovascular disease or obstructive sleep apnoea and a history of at least one patient-reported unsuccessful dietary effort to lose body weight, who have tried unsuccessfully to lose weight with diet alone